Ascentage Pharma Group International American Depository Shares Financial Statements
NASDAQ: AAPGHealth CareBiotechnology: Pharmaceutical PreparationsUSD
14.75+0.20 (+1.37%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ascentage Pharma Group International American Depository Shares revenue and earnings
In fiscal 2024, Ascentage Pharma Group International American Depository Shares generated $134.3 million in revenue. Ascentage Pharma Group International American Depository Shares reported a net loss of $55.5 million. Gross margin was 97.0%.
Diluted earnings per share came in at -$0.18.
Summary generated from market data by MetaCap's automated system. Methodology
Ascentage Pharma Group International American Depository Shares income statement (annual)
| Fiscal year (USD) | FY 20242024-12-31 |
|---|---|
| Revenue | 134.35M |
| Revenue growth (YoY) | — |
| Cost of Revenue | 3.98M |
| Gross Profit | 130.36M |
| Research & Development | 129.77M |
| Interest Expense | 8.83M |
| Other Income (Expense) | 196.00K |
| Pretax Income | -54.15M |
| Income Tax | 1.43M |
| Net Income | -55.54M |
| Net Income growth (YoY) | — |
| EPS (Basic) | -0.18 |
| EPS (Diluted) | -0.18 |
| Shares Outstanding (Basic) | 302.06M |
| Gross Margin | 97.03% |
| Net Margin | -41.34% |
Values in USD; B = billions, M = millions. Fiscal periods follow AAPG's reporting calendar. What is a income statement?